Two gene ther­a­py ap­provals head­line CBER’s FY 2018 re­port

The FDA Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search (CBER) on Wednes­day pub­lished its fis­cal year 2018 re­port, high­light­ing two gene ther­a­py ap­provals, as well as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.